18F-Labeled FBPA Synthesis via Segmented Fluorination and Boronation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing boron-containing drugs for boron neutron capture therapy (BNCT) are inefficient and lack a simple process for synthesizing 18F-labeled 2-fluoro-4-borono-phenylalanine (FBPA), which is crucial for both BNCT and positron emission tomography (PET).
Innovation Solution
A novel intermediate is developed with specific structures and a method involving alkaline reactions, organometallic bases, and palladium catalysts to synthesize 18F-labeled FBPA, including fluorination and boronation reactions, to improve efficiency and yield.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional methods are used to prepare boron-containing drugs, then the synthesis process is established, but the preparation efficiency and yield are low
Solution Approach 1:
The synthesis process is divided into distinct sequential steps: fluorination reaction to introduce 18F, followed by boronation reaction to introduce boron group. Each step is optimized independently with specific temperature ranges and reagents, allowing for better control and higher overall efficiency while maintaining manageable complexity through modular processing
Solution Approach 2:
The patent employs specific parameter optimizations including temperature control (-80°C to 0°C for fluorination), solvent selection (acetonitrile, dichloromethane, or dimethylformamide), and reagent ratios to maximize reaction efficiency and yield at each stage, transforming the conventional approach into a high-efficiency process
2Manufacturing precision
If conventional synthesis methods are used, then the basic drug structure can be obtained, but the specific activity and yield of 18F-labeled FBPA are insufficient
Solution Approach 1:
The fluorination reaction is performed first to introduce the 18F label before the boronation step, ensuring high specific activity is established early in the synthesis. This preliminary labeling approach allows subsequent boron introduction without compromising the radioactive label's specific activity, while the optimized two-step sequence maintains high overall yield
Solution Approach 2:
The patent uses specific intermediates with defined structures (formulae 1-8) that facilitate both high specific activity and yield. The intermediate compounds serve as precise mediators that carry the 18F label through the synthesis process while enabling efficient boron introduction in the second step, achieving both high specificity and productivity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method allows for the simple and effective preparation of 18F-labeled FBPA with good specific activity, enhancing the efficiency and yield of synthesizing the boron-containing drug for BNCT and PET applications.
Implementation Method 1
A fluorination reaction is performed for the intermediate and a fluorinating reagent to generate a first compound
Implementation Method 2
performing a boronation reaction for the first compound and a boronating reagent to generate a second compound
Implementation Method 3
The second compound is hydrolyzed to generate 2-fluoro-4-borono-phenylalanine
Data Source
AI summary
An intermediate is provided and has the structure shown in formula (1) as follows: in which R1 is -Cl, -Br, -I, -OSO2CF3, -B(OH)2, or , R2 is -F, -18F, -Cl, -Br, -I, -SnMe3, -SnBu3, -B(OH)2, or and A is a chiral auxiliary.